Elevated ALT levels in those who subsequently develop T2DM may indicate the existence of a condition called non-alcoholic fatty liver disease (NAFLD), a disorder closely associated with metabolic syndrome and insulin resistance. This evidence concerns the gene GPT and metabolic syndrome.